Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home Search
diagnostics - search results
If you're not happy with the results, please do another search
AI & digital transformation in cancer care
Artificial intelligence and digital transformation play an important role in improving cancer diagnosis, treatments and increasing cancer survival rates, writes Dee Mathieson, Senior Vice President Linac Service and Managing Director of Elekta Ltd.
Artificial Intelligence solutions for healthcare delivery
Chaith Kondragunta, CEO at AIRA Matrix Private Limited, details Artificial Intelligence-based solutions that can positively impact prostate cancer outcomes.
Chaith Kondragunta – CEO AIRA Matrix Private Limited
Chaith Kondragunta is the CEO of AIRAMatrix Pvt. Ltd based in Mumbai, India. AIRAMatrix develops and provides AI powered solutions to the Life Sciences industry. The company’s solutions help improve work flow efficiency and increase accuracy in research labs, drug discovery studies and clinical diagnostics.
Autopsies: The dead serving the living
How forensic autopsies are not only used to determine a cause of death, but also to support medical research and development
Artificial intelligence & other cancer screening innovations
General Manager, Hologic UK and Ireland, keeps us up to speed with grasping the possibilities of AI and other innovations in cancer screening
Better prognosis identification with prostate cancer urine tests
Researchers at University of East Anglia have discovered that a prostate cancer urine test could improve the identification of men at ‘immediate risk’ of aggressive cancer, offering improved treatment methods.
How will the budget impact the life sciences industry?
Doris-Ann Williams MBE, BIVDA CEO, discusses the impacts of the latest government budget for the diagnostics and life sciences sector.
NHS says Autumn Budget “missed opportunity” to solve staffing crisis
NHS analysis of the Autumn Budget finds that Health spending will return to 2010 levels, but is a "missed opportunity" to solve the staffing crisis - currently, the workforce is 90,000 people short.
Driving the digital-first future of pathology through partnerships
Afshin Attari, Senior Director of Public Sector & Unified Platforms at Exponential-e, describes driving the digital-first future of pathology through partnerships.
Increasing community testing to clear the NHS backlog
Doris-Ann Williams MBE, CEO, BIVDA, calls for increased community testing as a way to clear the NHS backlog and deal with the increasing number of people who are living with undiagnosed diseases in the UK.
One in seven patients missed cancer surgery during lockdown
A new study reveals that one in seven patients missed their cancer surgery during lockdown, globally.
Factory farming, zoonotic disease and the risk of pandemics
Compassion in World Farming Research Manager dissects some of the dangers of the factory farming industry, discussing the spread of zoonotic diseases.
Report documents 17% higher rate of COVID death in North England
The Northern Health Science Alliance report says the North of England experienced a 17% higher rate of COVID death than the South - because of "higher deprivation and worse pre-pandemic health".
Glycoscience offers opportunities galore in healthcare
Aarthi JanakiRaman, Research Director, Chemicals and Advanced Materials at TechVision, Frost & Sullivan, explains how glycoscience offers opportunities galore in healthcare.
Optimising infection control post-pandemic
Luke S. P. Moore, Infectious Diseases Physician and Clinical Microbiologist on behalf of the Healthcare Infection Society, directs our thoughts to optimising our control of infections and looks forward to the post-pandemic period.
Health innovation is key to resolving challenges faced by the NHS
Lorna Green, Director of Enterprise and Growth, describes the role of the Innovation Agency and the AHSN Network across England and how health innovation is increasingly becoming integral to resolving the long-term challenges faced by the NHS.
9 in 10 adults have COVID-19 antibodies, according to new survey
A new Government survey has found that 9 in 10 adults have COVID-19 antibodies, but experts say more data is needed before 'Freedom Day'.
DPYD genotyping to improve patients’ therapy response
Here Yourgene Health, a molecular diagnostics company with products and technologies that enable precision medicine in oncology from bench to clinic, discuss genetic testing - or more specifically, pharmacogenomics.
Precision medicine: From bench to clinic
Here, we find out about Yourgene Health, a molecular diagnostics company with products and technologies that enable precision medicine in oncology from bench to clinic.
Accelerating the discovery, manufacture and translation of biomedical materials
The Henry Royce Institute is enhancing the UK’s position as an international leader in the field of biomedical materials, systems and devices.
